Delivery Order SPE2DB20D3304-SPE2DB25FW8P6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,883.72 for Lisdexamfetamine 30 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under the company's broader pharmaceutical supply arrangements with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100-count units) with a ceiling value of $1,621.18. This competitively awarded, firm fixed-price delivery order is not set-aside and has an ultimate completion date of August 15, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units) with a contract ceiling value of $2,727.39. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count) with a ceiling value of $2,031.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100 count) with a ceiling value of $5,774.04. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 8, 2025. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,706.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 10 mg capsules (100 count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply relationship with the DLA. This award is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lisdexamfetamine 60 mg capsules (90-count) with a ceiling value of $1,082.56. This firm fixed price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lisdexamfetamine 70 mg capsules (90-count units) under a firm fixed-price contract valued at $1,735.76. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,125.58 and has an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp will perform this contract from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW8P6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of lisdexamfetamine 30 mg capsules (100-count units) with a ceiling value of $2,118.80. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, issued under a competitively awarded, non-set-aside contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive prime vendor agreement valued at $999,999,999.00 and running through December 2026. This prime vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contract portfolio demonstrates extensive capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains for defense and military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/18/25 |